Back to search

Article

Dienogest interrupts the chemokine signalling axis in endometriotic lesions with resistant signatures providing novel opportunities for personalised treatment.

2026-01-13

Abstract excerpt

<title>Abstract</title> <p>Progestins are important first line and adjuvant medications for endometriosis, yet their efficacy varies among patients. Dienogest (DNG), a 4th generation progestin, is one of the most prescribed and successful progestins, although a subset of patients remain refractory to treatment. A prospective method to match patients to DNG, or other treatments could significantly improve patient...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4f5a1383-a6c5-5777-bec5-6880e4575bbe
DOI
10.21203/rs.3.rs-8096027/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dienogest interrupts the chemokine signalling axis in endometriotic lesions with resistant signatures providing novel opportunities for personalised treatment.DOI 10.21203/rs.3.rs-8096027/v1
Select a neighboring publication to make it the new centre.